Amazon, Berkshire Hathaway, JPMorgan partner to address healthcare of 1.1M employees

Amazon, Berkshire Hathaway and JPMorgan Chase announced Tuesday morning an initiative aimed at improving healthcare for their combined 1.1 million U.S.-based employees. The three corporate giants want to improve employee satisfaction while reducing costs.

The new company will be “free from profit-making incentives and constraints,” according to a news release, and will look for technological solutions to the “enormous challenges of healthcare.”

"The ballooning costs of healthcare act as a hungry tapeworm on the American economy. Our group does not come to this problem with answers. But we also do not accept it as inevitable. Rather, we share the belief that putting our collective resources behind the country's best talent can, in time, check the rise in health costs while concurrently enhancing patient satisfaction and outcomes," said Warren Buffett, Berkshire Hathaway Chairman and CEO.

The release did not spell out specific details or of the partnership, noting that the effort is in its “early planning stages.” It will be led by one representative from each of the three companies, with a management team, headquarters and operational details to be determined.

“The healthcare system is complex, and we enter into this challenge open-eyed about the degree of difficulty,” said Jeff Bezos, Amazon founder and CEO. “Hard as it might be, reducing healthcare’s burden on the economy while improving outcomes for employees and their families would be worth the effort. Success is going to require talented experts, a beginner’s mind, and a long-term orientation.”

Todd Combs, an investment officer of Berkshire Hathaway; Marvelle Sullivan Berchtold, a managing director of JPMorgan Chase; and Beth Galetti, a senior vice president at Amazon, will spearhead the initiative.

The announcement had an immediate impact on the stock prices of other healthcare industry leaders. In premarket trading, CVS, UnitedHealth and Express Scripts saw shares plummet by at least 7 percent, according to CNBC. Aetna saw shares drop by 3 percent.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”